Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV

This study has been completed.
Taixing People's Hospital
Fourth People's Hospital of Zhenjiang, China
Wuxi Maternal and Child Health Hospital
Kunshan First People Hospital
Information provided by (Responsible Party):
Yi-Hua Zhou, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Identifier:
First received: July 4, 2012
Last updated: November 30, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)